Excell Biotech

Manufacturer and suppler of generic drugs

placeShanghai, Shanghai, China calendar_todayFounded 2013 language excellbio.com

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 6 times.

YearFilings
20201

Investor mix

3 investors on record; lead investors include Yonghua Capital.

Investor typeCountShare
Private equity133%
Other / undisclosed267%
Coming soon